KR Choksey's research report on Persistent Systems
PSYS delivered 22.6% YoY revenue growth in Q3FY25, driven by strong vertical performance and acquisitions. EBIT grew 25.5% YoY, while PAT surged 30.4% YoY, reflecting improved margins and robust execution. However, the outlook for FY24-FY27E (Revenue/PAT: 20.1%/ 25.1%) suggests a notable deceleration in growth compared to its historical performance, indicating a potential slowdown in momentum. We revise our EPS estimates for FY26E/FY27E upwards by 8.0%/8.2% to INR 110.9/137.3, respectively (previously INR 102.7/126.9), factoring in Q3FY25 performance, strong deal wins, along with margin expansion.
Outlook
Rolling over our valuation to FY27E and assigning a P/E multiple of 54.0x, we arrive at a target price of INR 5,989 (earlier: INR 5,441). Furthermore, the stock is currently priced at an all-time high 1-Year Forward P/E of 70.2x, significantly exceeding its three-year average of 35.6x. This widening gap between the stock's price and its fundamental performance raises concerns about the risk-reward profile. As a result, we maintain our "REDUCE" rating, reflecting a cautious view on PSYS shares.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.